SB-334867 free base (Synonyms: SB334867A free base)
目录号: PL08108 纯度: ≥99%
CAS No. :792173-99-0
商品编号 规格 价格 会员价 是否有货 数量
PL08108-5mg 5mg ¥865.45 请登录
PL08108-10mg 10mg ¥1483.64 请登录
PL08108-50mg 50mg ¥4883.64 请登录
PL08108-100mg 100mg 询价 询价
PL08108-200mg 200mg 询价 询价
PL08108-10mM*1mLinDMSO 10mM*1mLinDMSO ¥952.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
SB-334867 free base
中文别名
1-(2-甲基苯并[d]噁唑-6-基)-3-(1,5-萘啶-4-基)脲;SB334867 抑制剂;N-(2-甲基-6-苯并恶唑基)-N'-1,5-二氮杂萘-4-基脲
英文名称
SB-334867 free base
英文别名
1-(2-methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea;N-(2-METHYL-6-BENZOOXAZOLYL)-N''-1,5-NAPHTHYRIDIN-4-YL UREA;SB-334867 free base;N-​(2-​methyl-​6-​benzoxazolyl)​-​N'-​1,​5-​naphthyridin-​4-​yl;SB 334867;Urea,N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl-;SB334867 free base;SB334867A free base;N-(2-Methyl-6-benzoxazolyl)-N′-1,5-naphthyridin-4-yl-urea;SB-334867;SB-334867A;SB-334867 (free base);SB334867;N-(2-METHYL-6-BENZOXAZOLYL)-N'-1,5-NAPHTHYRIDIN-4-YL UREA;N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl-Urea;1-(2-Methyl-benzooxazol-6-yl)-3-[1,5]naphthyridin-4-yl-urea;1-(2-Methylbenzo[d]oxazol-6-yl)-1-(1,5-naphthyridin-4-yl)urea;1-(2-methyl-1
Cas No.
792173-99-0
分子式
C17H13N5O2
分子量
319.32
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
SB-334867 free base (SB334867A free base) 是一种优良的选择性血脑屏障通透性 orexin-1 (OX1) receptor 拮抗剂,对 OX2 有选择性 (pKb=7.4),对 5-HT2B、5-HT2C 的选择性是 100 倍,pKi 值分别为 5.4 和 5.3。SB-334867 降低体内乙醇消耗量,抑制吗啡诱导的对运动活性的增敏。
生物活性
SB-334867 free base (SB334867A free base) is an excellent, selective and blood–brain barrier permeable orexin-1 (OX1) receptor antagonist, shows selectivity over OX2 (pK b =7.4), 100-fold over 5-HT 2B , 5-HT 2C with pK i values of 5.4 and 5.3, respectively. SB-334867 reduces ethanol consumption and inhibits the acquisition of morphine-induced sensitization to locomotor activity in vivo.
性状
Solid
IC50 & Target[1][2]
OX2 ()
体外研究(In Vitro)
SB-334867 (100?pM–?10?μM) inhibits the orexin-A (10?nM) and orexin-B (100?nM)-induced calcium responses in a concentration-dependent manner, with apparent pKb values of 7.27±0.04 and 7.23±0.03, but has no effect on the calcium response elicited by UTP (3?μM), which activates an endogenous purinergic receptor in CHO-OX1 and CHO-OX2 cells.
has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
SB-334867 (intraperitoneal injection; 20 mg/kg; 20 days) administers 15 min before morphine injection can significantly decrease the effect of the morphine challenge dose in mice in comparison with the sporadically morphine-treated group.
SB-334867 (intraperitoneal injection; 3, 10 and 30 mg/kg) significantly reduces ethanol intake relative to vehicle and does not effect water consumption in female P rats.
SB-334867 (intraperitoneal injection; 3, 10 and 30 mg/kg) reduces ethanol consumption at the 30 mg/kg dose, high dose suppresses sucrose intake relative to vehicle, and it results in lower blood ethanol concentrations (BECs) relative to both the 10 and 30 mg/kg doses.
has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Porter RA, et al. 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor.Bioorg Med Chem Lett. 2001 Jul 23;11(14):1907-10.
[2]. ?upina M, et al. SB-334867 (an Orexin-1 Receptor Antagonist) Effects on Morphine-Induced Sensitization in Mice-a View on Receptor Mechanisms.
溶解度数据
In Vitro: DMSO : 50 mg/mL (156.58 mM; Need ultrasonic)0.1 M HCL : 6 mg/mL (18.79 mM; ultrasonic and adjust pH to 3 with HCl)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2